Peggy Mérida

818 total citations
15 papers, 325 citations indexed

About

Peggy Mérida is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Peggy Mérida has authored 15 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Infectious Diseases and 3 papers in Virology. Recurrent topics in Peggy Mérida's work include SARS-CoV-2 and COVID-19 Research (4 papers), HIV Research and Treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Peggy Mérida is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), HIV Research and Treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Peggy Mérida collaborates with scholars based in France, Germany and Australia. Peggy Mérida's co-authors include Delphine Muriaux, Cyril Favard, Johnson Mak, Sébastien Lyonnais, Christine Chable-Bessia, Naresh Yandrapalli, Jakub Chojnacki, Christian Eggeling, Aymeric Neyret and Roger Lahana and has published in prestigious journals such as Blood, The Journal of Immunology and Scientific Reports.

In The Last Decade

Peggy Mérida

15 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peggy Mérida France	12	160	85	58	39	32	15	325
Elena Mekhedov United States	6	268 1.7×	40 0.5×	13 0.2×	44 1.1×	18 0.6×	9	379
Stefan Petkov Sweden	10	132 0.8×	55 0.6×	60 1.0×	112 2.9×	9 0.3×	33	321
Daniel H. Lin United States	11	929 5.8×	53 0.6×	68 1.2×	69 1.8×	24 0.8×	14	1.1k
Floriane Herit France	9	136 0.8×	58 0.7×	62 1.1×	171 4.4×	12 0.4×	13	418
Michael A. Thomas United States	10	102 0.6×	76 0.9×	139 2.4×	103 2.6×	9 0.3×	18	380
Nikolaos Tsopoulidis Germany	9	150 0.9×	23 0.3×	50 0.9×	68 1.7×	11 0.3×	11	265
Joshua A. Jadwin United States	9	221 1.4×	72 0.8×	121 2.1×	76 1.9×	13 0.4×	10	388
Nijing Sheng United States	8	358 2.2×	63 0.7×	72 1.2×	33 0.8×	4 0.1×	9	524
C. Todd DeMarco United States	6	231 1.4×	85 1.0×	39 0.7×	53 1.4×	6 0.2×	10	343
Iwen F. Grigsby United States	10	128 0.8×	66 0.8×	79 1.4×	195 5.0×	6 0.2×	14	422

Countries citing papers authored by Peggy Mérida

Since Specialization

Citations

This map shows the geographic impact of Peggy Mérida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peggy Mérida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peggy Mérida more than expected).

Fields of papers citing papers by Peggy Mérida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peggy Mérida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peggy Mérida. The network helps show where Peggy Mérida may publish in the future.

Co-authorship network of co-authors of Peggy Mérida

This figure shows the co-authorship network connecting the top 25 collaborators of Peggy Mérida. A scholar is included among the top collaborators of Peggy Mérida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peggy Mérida. Peggy Mérida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Swain, Jitendriya, Peggy Mérida, Karla Rubio, et al.. (2023). F-actin nanostructures rearrangements and regulation are essential for SARS-CoV-2 particle production in host pulmonary cells. iScience. 26(8). 107384–107384. 2 indexed citations

Chable-Bessia, Christine, Charlotte Boullé, Aymeric Neyret, et al.. (2022). Low Selectivity Indices of Ivermectin and Macrocyclic Lactones on SARS-CoV-2 Replication In Vitro. COVID. 2(1). 60–75. 11 indexed citations

Salehi, Hamideh, Anuradha Ramoji, Peggy Mérida, et al.. (2022). Specific intracellular signature of SARS-CoV-2 infection using confocal Raman microscopy. Communications Chemistry. 5(1). 85–85. 5 indexed citations

Swain, Jitendriya, Peggy Mérida, Saveez Saffarian, et al.. (2022). Optimized production and fluorescent labeling of SARS-CoV-2 virus-like particles. Scientific Reports. 12(1). 14651–14651. 25 indexed citations

Mérida, Peggy, et al.. (2022). Extracellular vesicles containing the I‐BAR protein IRSp53 are released from the cell plasma membrane in an Arp2/3 dependent manner. Biology of the Cell. 114(10). 259–275. 15 indexed citations

Lyonnais, Sébastien, Aymeric Neyret, Peggy Mérida, et al.. (2021). Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions. Scientific Reports. 11(1). 11885–11885. 38 indexed citations

Constant, Orianne, Jonathan Barthelemy, Karine Bolloré, et al.. (2021). SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects. Frontiers in Immunology. 12. 697329–697329. 27 indexed citations

Tsai, Feng‐Ching, John Manzi, Peggy Mérida, et al.. (2021). Full assembly of HIV-1 particles requires assistance of the membrane curvature factor IRSp53. eLife. 10. 25 indexed citations

Favard, Cyril, Jakub Chojnacki, Peggy Mérida, et al.. (2019). HIV-1 Gag specifically restricts PI(4,5)P2 and cholesterol mobility in living cells creating a nanodomain platform for virus assembly. Science Advances. 5(10). eaaw8651–eaaw8651. 59 indexed citations

10.

Masson, Jean‐Baptiste, Sonia Georgeault, Peggy Mérida, et al.. (2018). Single molecule localisation microscopy reveals how HIV-1 Gag proteins sense membrane virus assembly sites in living host CD4 T cells. Scientific Reports. 8(1). 16283–16283. 33 indexed citations

11.

Mérida, Peggy, et al.. (2007). Applications of a Blood-Brain Barrier Technology Platform to Predict CNS Penetration of Various Chemotherapeutic Agents. 2. Cationic Peptide Vectors for Brain Delivery. Chemotherapy. 53(1). 73–76. 21 indexed citations

12.

Blanc, Emmanuelle, Cécile Bonnafous, Peggy Mérida, et al.. (2004). Peptide-vector strategy bypasses P-glycoprotein efflux, and enhances brain transport and solubility of paclitaxel. Anti-Cancer Drugs. 15(10). 947–954. 17 indexed citations

13.

Castex, Cédric, Peggy Mérida, Emmanuelle Blanc, et al.. (2004). 2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistance. Anti-Cancer Drugs. 15(6). 609–617. 6 indexed citations

14.

Adjali, Oumeya, Louise Swainson, Peggy Mérida, et al.. (2004). T-cell receptor–induced phosphorylation of the ζ chain is efficiently promoted by ZAP-70 but not Syk. Blood. 104(3). 760–767. 22 indexed citations

15.

Dauvillier, Stéphanie, et al.. (2002). Intracellular Single-Chain Variable Fragments Directed to the Src Homology 2 Domains of Syk Partially Inhibit FcεRI Signaling in the RBL-2H3 Cell Line. The Journal of Immunology. 169(5). 2274–2283. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact